Isotretinoin-Induced Delusional Disorder, Somatic Subtype
Joint Authors
Jensen, Katharine V.
Abba-Aji, Adam
Source
Case Reports in Dermatological Medicine
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-07-26
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne.
Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects.
Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness.
The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day.
Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine.
American Psychological Association (APA)
Jensen, Katharine V.& Abba-Aji, Adam. 2020. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904
Modern Language Association (MLA)
Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1146904
American Medical Association (AMA)
Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1146904